We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Content type

Tags

Firm name

Author

Language

833 results found

Article

AA Thornton | United Kingdom | 20 Nov 2018

Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (PregabalinLyrica)

The Supreme Court of the United Kingdom has now released their long-awaited decision relating to the tests for sufficiency and infringement for second

Article

Freshfields Bruckhaus Deringer | United Kingdom, European Union | 14 Nov 2018

UK Supreme Court patent decision in Lyrica: What you need to know

The UK Supreme Court handed down its much anticipated judgment in the Warner-Lambert v Mylan and Actavis (Lyrica) case today (

Article

Knobbe Martens | USA | 11 Sep 2018

Orexo AB, Orexo US INC., v Actavis Elizabeth LLC

Objective indicia of nonobviousness cannot be dismissed merely because all the ingredients in a formulation were generally known and nothing prevented

Article

Rothwell, Figg, Ernst & Manbeck, PC | USA | 7 Aug 2018

Using Theses as Prior Art at the PTAB

Based on recent Patent Trial and Appeal Board (“PTAB” or “the Board”) decisions, the best practice to establish an academic thesis as a printed

Article

Boult Wade Tennant LLP | USA, United Kingdom | 3 Jul 2018

Innovation key to driving success in healthcare

As the NHS turns 70, it is notable that the focus for the future is on innovation for the improvement of patient care. Technologies spanning genetic

Article

Baker McKenzie | Singapore | 30 Apr 2018

Purposive approach to patent claim construction and counterclaims for groundless threats - Lee Tat Cheng v Maka GPS Technologies Pte Ltd 2018 SGCA 18

Lee Tat Cheng (the "Appellant") is the proprietor of a patent in respect of an inautomotive accident recordal system. In the High Court in Lee Tat

Article

Ladas & Parry LLP | United Kingdom | 19 Mar 2018

UK SUPREME COURT DECISION IN ACTAVIS v. ELI LILLY - DOCTRINE OF EQUIVALENTS RECOGNIZED

In its decision of July 12, 2017 in Actavis v. Eli Lilly, the Supreme Court of the United Kingdom for the first time formally adopted the

Article

Bird & Bird | United Kingdom | 7 Dec 2017

Equivalents Unchained

The Actavis v Eli Lilly decision of the UK Supreme Court has been described by some commentators as being a minor gloss on the law of patent

Article

Bristows | Netherlands, United Kingdom, European Union | 27 Nov 2017

Dutch Health Council’s proposal of compulsory licensing as solution to high pharma prices

Shortly before becoming the new home of the EMA, the Netherlands piqued the interest of the pharma industry with a controversial move on drug pricing

Article

Gowling WLG | United Kingdom, Canada, European Union | 27 Nov 2017

Actavis v Eli Lilly

Following the Supreme Court's decision in Actavis v Lilly, is there a gap between the interpretation of a patent claim for validity purposes and its

Previous page 1 2 3 ...